BTG (LON: BTG)‘s stock had its “overweight” rating reaffirmed by research analysts at JP Morgan Cazenove in a report released on Tuesday. They currently have a $6.39 (425 GBX) target price on the stock.

BTG opened at 329.20 on Tuesday. BTG has a 1-year low of GBX 297.00 and a 1-year high of GBX 426.00. The stock’s 50-day moving average is currently GBX 0..

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.